Pituitary stalk interruption syndrome in 58 Chinese patients: Clinical features and genetic analysis

Clinical Endocrinology

Volumn 79, Issue 1, 2013, Pages 86-92

  Yang, Yan ^a   Guo, Qing Hua ^a   Wang, Bao An ^a   Dou, Jing Tao ^a   Lv, Zhao Hui ^a   Ba, Jian Ming ^a   Lu, Ju Ming ^a   Pan, Chang Yu ^a   Mu, Yi Ming ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; FOLLITROPIN; HYPOPHYSIS HORMONE; LUTEINIZING HORMONE; THYROTROPIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HESX1; TRANSCRIPTION FACTOR LHX4; TRANSCRIPTION FACTOR OTX2; TRANSCRIPTION FACTOR SOX3; UNCLASSIFIED DRUG;

ADENOHYPOPHYSIS DISEASE; ADOLESCENT; ADULT; ARTICLE; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOTROPIN DEFICIENCY; ECTOPIC ORGAN; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; GROWTH HORMONE DEFICIENCY; HEMIZYGOTE; HETEROZYGOTE; HUMAN; HYPOPLASIA; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE DISEASE; NEUROHYPOPHYSIS; PITUITARY STALK; PITUITARY STALK INTERRUPTION SYNDROME; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RETROSPECTIVE STUDY; SCREENING;

ADOLESCENT; AMINO ACID SEQUENCE; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GROWTH HORMONE; HOMEODOMAIN PROTEINS; HUMANS; LIM-HOMEODOMAIN PROTEINS; MALE; MOLECULAR SEQUENCE DATA; OTX TRANSCRIPTION FACTORS; PITUITARY DISEASES; PITUITARY GLAND; POLYMORPHISM, GENETIC; RECEPTORS, NEUROPEPTIDE; RECEPTORS, PITUITARY HORMONE-REGULATING HORMONE; RETROSPECTIVE STUDIES; SEQUENCE HOMOLOGY, AMINO ACID; SOXB1 TRANSCRIPTION FACTORS; SYNDROME; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84878535545     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12116     Document Type: Article

References (35)

1. Gascoin-Lachambre, G., Brauner, R., Duche, L., et al,. (2011) Pituitary stalk interruption syndrome: diagnostic delay and sensitivity of the auxological criteria of the growth hormone research society. PLoS ONE, 6, e16367.
2. Rottembourg, D., Linglart, A., Adamsbaum, C., et al,. (2008) Gonadotrophic status in adolescents with pituitary stalk interruption syndrome. Clinical Endocrinology, 69, 105-111.
3. Reynaud, R., Albarel, F., Saveanu, A., et al,. (2011) Pituitary stalk interruption syndrome in 83 patients: novel HESX1 mutation and severe hormonal prognosis in malformative forms. European Journal of Endocrinology, 164, 457-465.
4. Tauber, M., Chevrel, J., Diene, G., et al,. (2005) Long-term evolution of endocrine disorders and effect of GH therapy in 35 patients with pituitary stalk interruption syndrome. Hormone Research, 64, 266-273.
5. El Chehadeh-Djebbar, S., Callier, P., Masurel-Paulet, A., et al,. (2011) 17q21.31 microdeletion in a patient with pituitary stalk interruption syndrome. European Journal of Medical Genetics, 54, 369-373.
6. Pinto, G., Netchine, I., Sobrier, M.L., et al,. (1997) Pituitary stalk interruption syndrome: a clinical-biological-genetic assessment of its pathogenesis. Journal of Clinical Endocrinology and Metabolism, 82, 3450-3454.
7. Trivin, C., Gluckman, E., Leblanc, T., et al,. (2007) Factors and markers of growth hormone secretion and gonadal function in Fanconi anemia. Growth Hormone & IGF Research: 17, 122-129.
8. Simon, D., Hadjiathanasiou, C., Garel, C., et al,. (2006) Phenotypic variability in children with growth hormone deficiency associated with posterior pituitary ectopia. Clinical Endocrinology, 64, 416-422.
9. Reynaud, R., Gueydan, M., Saveanu, A., et al,. (2006) Genetic screening of combined pituitary hormone deficiency: experience in 195 patients. Journal of Clinical Endocrinology and Metabolism, 91, 3329-3336.
10. Arrigo, T., Wasniewska, M., De Luca, F., et al,. (2006) Congenital adenohypophysis aplasia: clinical features and analysis of the transcriptional factors for embryonic pituitary development. Journal of Endocrinological Investigation, 29, 208-213.
11. Dattani, M.T., (2005) Growth hormone deficiency and combined pituitary hormone deficiency: does the genotype matter? Clinical Endocrinology, 63, 121-130.
12. Melo, M.E., Marui, S., Carvalho, L.R., et al,. (2007) Hormonal, pituitary magnetic resonance, LHX4 and HESX1 evaluation in patients with hypopituitarism and ectopic posterior pituitary lobe. Clinical Endocrinology, 66, 95-102.
13. Ashkenazi-Hoffnung, L., Lebenthal, Y., Wyatt, A.W., et al,. (2010) A novel loss-of-function mutation in OTX2 in a patient with anophthalmia and isolated growth hormone deficiency. Human Genetics, 127, 721-729.
14. Woods, K.S., Cundall, M., Turton, J., et al,. (2005) Over- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism. American Journal of Human Genetics, 76, 833-849.
15. Rocha, M.G., Marchisotti, F.G., Osorio, M.G., et al,. (2008) High prevalence of pituitary magnetic resonance abnormalities and gene mutations in a cohort of Brazilian children with growth hormone deficiency and response to treatment. Journal of Pediatric Endocrinology and Metabolism, 21, 673-680.
16. Argyropoulou, M., Perignon, F., Brauner, R., et al,. (1992) Magnetic-resonance-imaging in the diagnosis of growth-hormone deficiency. Journal of Pediatrics, 120, 886-891.
17. Li, H., Ji, C.Y., Zong, X.N., et al,. (2009) Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years. Zhonghua Er Ke Za Zhi. Chinese Journal of Pediatrics, 47, 487-492.
18. Fok, T., Hon, K., So, H.K., et al,. (2005) Normative data of penile length for term Chinese newborns. Biology of the Neonate, 87, 242-245.
19. Greulich, W.W., &, Pyle, S.I., (1959) Radiographic atlas of skeletal development of the hand and wrist. American Journal of Medicine, 238, 393.
20. Alatzoglou, K.S., Turton, J.P., Kelberman, D., et al,. (2009) Expanding the spectrum of mutations in GH1 and GHRHR: genetic screening in a large cohort of patients with congenital isolated growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 94, 3191-3199.
21. Xiang, F., Buervenich, S., Nicolao, P., et al,. (2000) Mutation screening in Rett syndrome patients. Journal of Medical Genetics, 37, 250-255.
22. Chen, S., Leger, J., Garel, C., et al,. (1999) Growth hormone deficiency with ectopic neurohypophysis: anatomical variations and relationship between the visibility of the pituitary stalk asserted by magnetic resonance imaging and anterior pituitary function. Journal of Clinical Endocrinology and Metabolism, 84, 2408-2413.
23. Fernandez-Rodriguez, E., Quinteiro, C., Barreiro, J., et al,. (2011) Pituitary stalk dysgenesis-induced hypopituitarism in adult patients: prevalence, evolution of hormone dysfunction and genetic analysis. Neuroendocrinology, 93, 181-188.
24. Marcu, M., Trivin, C., Souberbielle, J.C., et al,. (2008) Factors influencing the growth hormone peak and plasma insulin-like growth factor I in young adults with pituitary stalk interruption syndrome. BMC Endocrine Disorders, 8, 7.
25. Dattani, M.T., Martinez-Barbera, J.P., Thomas, P.Q., et al,. (1998) Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nature Genetics, 19, 125-133.
26. Brickman, J.M., Clements, M., Tyrell, R., et al,. (2001) Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders. Development, 128, 5189-5199.
27. Machinis, K., Pantel, J., Netchine, I., et al,. (2001) Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. American Journal of Human Genetics, 69, 961-968.
28. Castinetti, F., Saveanu, A., Reynaud, R., et al,. (2008) A novel dysfunctional LHX4 mutation with high phenotypical variability in patients with hypopituitarism. Journal of Clinical Endocrinology and Metabolism, 93, 2790-2799.
29. Dateki, S., Fukami, M., Sato, N., et al,. (2008) OTX2 mutation in a patient with anophthalmia, short stature, and partial growth hormone deficiency: functional studies using the IRBP, HESX1, and POU1F1 promoters. Journal of Clinical Endocrinology and Metabolism, 93, 3697-3702.
30. Dateki, S., Kosaka, K., Hasegawa, K., et al,. (2010) Heterozygous orthodenticle homeobox 2 mutations are associated with variable pituitary phenotype. Journal of Clinical Endocrinology and Metabolism, 95, 756-764.
31. Diaczok, D., Romero, C., Zunich, J., et al,. (2008) A novel dominant negative mutation of OTX2 associated with combined pituitary hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 93, 4351-4359.
32. Tajima, T., Ohtake, A., Hoshino, M., et al,. (2009) OTX2 loss of function mutation causes anophthalmia and combined pituitary hormone deficiency with a small anterior and ectopic posterior pituitary. Journal of Clinical Endocrinology and Metabolism, 94, 314-319.
33. Alatzoglou, K.S., Kelberman, D., Cowell, C.T., et al,. (2011) Increased transactivation associated with SOX3 polyalanine tract deletion in a patient with hypopituitarism. Journal of Clinical Endocrinology and Metabolism, 96, E685-690.
34. Dateki, S., Fukami, M., Uematsu, A., et al,. (2010) Mutation and gene copy number analyses of six pituitary transcription factor genes in 71 patients with combined pituitary hormone deficiency: identification of a single patient with LHX4 deletion. Journal of Clinical Endocrinology and Metabolism, 95, 4043-4047.
35. Kabir, A.A., Steinmann, W.C., Myers, L., et al,. (2004) Unnecessary cesarean delivery in Louisiana: an analysis of birth certificate data. American Journal of Obstetrics and Gynecology, 190, 10-19.